TABLE 1.
Patient demographics for Canadian FH cohort
| Overall (N = 388) | Women (N = 212) | Men (N = 176) | |
| Age, years | 50.7 ± 15.2 | 52.1 ± 16.3 | 48.9 ± 13.6 |
| Body mass index, kg/m2 | 27.8 ± 5.9 | 27.3 ± 6.1 | 28.6 ± 5.5 |
| Total cholesterol, mmol/l | 8.94 ± 1.91 | 9.13 ± 1.94 | 8.66 ± 1.83 |
| LDL cholesterol, mmol/l | 6.79 ± 1.79 | 6.93 ± 1.80 | 6.60 ± 1.76 |
| HDL cholesterol, mmol/l | 1.35 ± 0.38 | 1.43 ± 0.39 | 1.22 ± 0.35 |
| Triglyceride, mmol/l | 1.79 ± 0.88 | 1.77 ± 0.98 | 1.81 ± 0.73 |
| Personal history of CVD,a % | 17.9 | 12.9 | 25.0 |
| Family history of CVD,a % | 40.0 | 44.7 | 50.0 |
| Definite or probable FH (DLCN score),a % | 65.5 | 67.1 | 63.3 |
Values are represented as mean ± SD. CVD indicates CVD onset <55 years in men and <60 years in women. DLCN, Dutch Lipid Clinic Network.
a
Based on complete data from 145 individuals.